Cargando…
AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
The Dermatomyositis Delphi Criteria Project created 25 provisional clinical, laboratory and contextual classification criteria after an extensive literature search, three rounds of consensus exercises and nominal group discussions. These criteria will be subjected to a case-control validation study...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033393/ http://dx.doi.org/10.21037/atm.2021.AB014 |
_version_ | 1783676405323661312 |
---|---|
author | Concha, Josef Symon S. Merola, Joseph F. Fiorentino, David Dutz, Jan Peter Goodfield, Mark Nyberg, Filippa Volc-Platzer, Beatrix Fujimoto, Manubo Ang, Chia Chun Werth, Victoria P. |
author_facet | Concha, Josef Symon S. Merola, Joseph F. Fiorentino, David Dutz, Jan Peter Goodfield, Mark Nyberg, Filippa Volc-Platzer, Beatrix Fujimoto, Manubo Ang, Chia Chun Werth, Victoria P. |
author_sort | Concha, Josef Symon S. |
collection | PubMed |
description | The Dermatomyositis Delphi Criteria Project created 25 provisional clinical, laboratory and contextual classification criteria after an extensive literature search, three rounds of consensus exercises and nominal group discussions. These criteria will be subjected to a case-control validation study to create a combination of items that will define a more inclusive cohort of DM patients with skin-predominant disease for clinical research. Several measurement properties that need to be assessed prior to the conduct of a multicenter prospective validation study include the final purpose of the criteria set, population and disease characteristics of cases and controls for study entry, sources of samples, definition of criteria items, methods of item ranking and reduction, and consideration of criteria set validity against a comparator backdrop “gold standard” criteria. An expert committee Delphi and several online discussions among participants from the fields of dermatology, and adult and pediatric rheumatology have been conducted in order to address such issues. Constant evaluation of the methodologic process is vital to produce classification criteria which are valid and reliable to identify patients with DM and delineate these patients from those with mimicker diseases. |
format | Online Article Text |
id | pubmed-8033393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-80333932021-04-09 AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study Concha, Josef Symon S. Merola, Joseph F. Fiorentino, David Dutz, Jan Peter Goodfield, Mark Nyberg, Filippa Volc-Platzer, Beatrix Fujimoto, Manubo Ang, Chia Chun Werth, Victoria P. Ann Transl Med Abstract on Rheumatologic Skin Disease The Dermatomyositis Delphi Criteria Project created 25 provisional clinical, laboratory and contextual classification criteria after an extensive literature search, three rounds of consensus exercises and nominal group discussions. These criteria will be subjected to a case-control validation study to create a combination of items that will define a more inclusive cohort of DM patients with skin-predominant disease for clinical research. Several measurement properties that need to be assessed prior to the conduct of a multicenter prospective validation study include the final purpose of the criteria set, population and disease characteristics of cases and controls for study entry, sources of samples, definition of criteria items, methods of item ranking and reduction, and consideration of criteria set validity against a comparator backdrop “gold standard” criteria. An expert committee Delphi and several online discussions among participants from the fields of dermatology, and adult and pediatric rheumatology have been conducted in order to address such issues. Constant evaluation of the methodologic process is vital to produce classification criteria which are valid and reliable to identify patients with DM and delineate these patients from those with mimicker diseases. AME Publishing Company 2021-03 /pmc/articles/PMC8033393/ http://dx.doi.org/10.21037/atm.2021.AB014 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Abstract on Rheumatologic Skin Disease Concha, Josef Symon S. Merola, Joseph F. Fiorentino, David Dutz, Jan Peter Goodfield, Mark Nyberg, Filippa Volc-Platzer, Beatrix Fujimoto, Manubo Ang, Chia Chun Werth, Victoria P. AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
title | AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
title_full | AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
title_fullStr | AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
title_full_unstemmed | AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
title_short | AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
title_sort | ab014. developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study |
topic | Abstract on Rheumatologic Skin Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033393/ http://dx.doi.org/10.21037/atm.2021.AB014 |
work_keys_str_mv | AT conchajosefsymons ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT merolajosephf ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT fiorentinodavid ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT dutzjanpeter ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT goodfieldmark ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT nybergfilippa ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT volcplatzerbeatrix ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT fujimotomanubo ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT angchiachun ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy AT werthvictoriap ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy |